Feil G - Search Results

1

Investigations of urothelial cells seeded on commercially available small intestine submucosa.

Feil G, Christ-Adler M, Maurer S, Corvin S, Rennekampff HO, Krug J, Hennenlotter J, Kuehs U, Stenzl A, Sievert KD. Feil G, et al. Eur Urol. 2006 Dec;50(6):1330-7. doi: 10.1016/j.eururo.2006.05.041. Epub 2006 Jun 16. Eur Urol. 2006. PMID: 16820260

2

Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.

Feil G, Maurer S, Nagele U, Krug J, Bock C, Sievert KD, Stenzl A. Feil G, et al. Eur Urol. 2008 May;53(5):1066-72. doi: 10.1016/j.eururo.2007.10.026. Epub 2007 Oct 23. Eur Urol. 2008. PMID: 17980954

3

In vitro investigations of tissue-engineered multilayered urothelium established from bladder washings.

Nagele U, Maurer S, Feil G, Bock C, Krug J, Sievert KD, Stenzl A. Nagele U, et al. Among authors: feil g. Eur Urol. 2008 Dec;54(6):1414-22. doi: 10.1016/j.eururo.2008.01.072. Epub 2008 Feb 4. Eur Urol. 2008. PMID: 18280635

4

Cytotoxic effects of treosulfan on prostate cancer cell lines.

Feyerabend S, Feil G, Krug J, Kassen A, Stenzl A. Feyerabend S, et al. Among authors: feil g. Anticancer Res. 2007 Jul-Aug;27(4B):2403-8. Anticancer Res. 2007. PMID: 17695531 Free article.

5

Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.

Feil G, Zumbrägel A, Päulgen-Nelde HJ, Hennenlotter J, Maurer S, Krause S, Bichler KH, Stenzl A. Feil G, et al. Anticancer Res. 2003 Mar-Apr;23(2A):963-7. Anticancer Res. 2003. PMID: 12820331

6

Combinations of urine-based tumour markers in bladder cancer surveillance.

Horstmann M, Patschan O, Hennenlotter J, Senger E, Feil G, Stenzl A. Horstmann M, et al. Among authors: feil g. Scand J Urol Nephrol. 2009;43(6):461-6. doi: 10.3109/00365590903296837. Scand J Urol Nephrol. 2009. PMID: 19903092

7

Clinical experience with survivin as a biomarker for urothelial bladder cancer.

Horstmann M, Bontrup H, Hennenlotter J, Taeger D, Weber A, Pesch B, Feil G, Patschan O, Johnen G, Stenzl A, Brüning T. Horstmann M, et al. Among authors: feil g. World J Urol. 2010 Jun;28(3):399-404. doi: 10.1007/s00345-010-0538-2. Epub 2010 Mar 23. World J Urol. 2010. PMID: 20309562

8

From tissue engineering to regenerative medicine in urology--the potential and the pitfalls.

Feil G, Daum L, Amend B, Maurer S, Renninger M, Vaegler M, Seibold J, Stenzl A, Sievert KD. Feil G, et al. Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):375-8. doi: 10.1016/j.addr.2010.12.003. Epub 2010 Dec 15. Adv Drug Deliv Rev. 2011. PMID: 21167237 Review.

9

In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair.

Drost AC, Weng S, Feil G, Schäfer J, Baumann S, Kanz L, Sievert KD, Stenzl A, Möhle R. Drost AC, et al. Among authors: feil g. Ann N Y Acad Sci. 2009 Sep;1176:135-43. doi: 10.1111/j.1749-6632.2009.04610.x. Ann N Y Acad Sci. 2009. PMID: 19796241

10

Significant alterations of serum cytokine levels in patients with Peyronie's disease.

Zimmermann RP, Feil G, Bock C, Hoeltl L, Stenzl A. Zimmermann RP, et al. Among authors: feil g. Int Braz J Urol. 2008 Jul-Aug;34(4):457-66; discussion 466. doi: 10.1590/s1677-55382008000400008. Int Braz J Urol. 2008. PMID: 18778497 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters